Skip to main content
OpenTrials
Completed

NCT Number: NCT05103865

Animal-Assisted Therapy in the Residential Treatment of Schizophrenia and Addictions

Animal-assisted therapy (AAT) is a complementary intervention of therapy that has shown positive results in the treatment of various pathologies. This study assesses the viability of the implementation and the efectiveness of an AAT program in patients diagnosed with substance abuse disorder and associated mental disorders (dual pathology).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Diagnosis, Dual (Psychiatry) Disease Mental Disorders Pathologic Processes Pathological Conditions, Signs and Symptoms Schizophrenia Schizophrenia Spectrum and Other Psychotic Disorders

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

Animal assisted therapy (AAT) is a complementary intervention to therapy that presents positive results in the treatment of different pathologies. The study assesses the implementation and effectiveness of a TAA program in patients diagnosed with substance use disorder and schizophrenia spectrum disorder.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Meeting DSM-5 criteria for substance abuse disorder and the presence of schizophrenia
  • Voluntary participant in the study and having signed the informed consent

Exclusion criteria

  • Patients whose functioning could be altered by factors not specifically related to addictive pathology or mental disorder (severe cognitive impairment, intellectual deficiency or language barrier)
  • Animal-specific phobia

Treatment and study plan

Animal-assisted therapy (AAT)

Behavioral

Other names: ATT

Usual treatment

Other

Primary outcomes

  1. The Life Skills Profile questionnaire (LSP)

    Time frame: Change from Life Skills at 3-6-9 months (12 minutes)

    This questionnaire evaluates aspects of functioning that affect daily activities and the adaptation of people with mental illnesses in the community. It contains 39 items that are grouped into self-care, social-interpersonal behaviour, communication-social contact, non-personal social behaviour and autonomous life

  2. Barrat impulsiveness scale (BIS-11)

    Time frame: Change from impulsiveness at 3-6-9 months (12 minutes)

    This instrument is composed of 30 items distributed into three sub-scales: nonplanning, motor and attentional. The total impulsiveness score was also obtained.

  3. Calgary Depresión Scale for Schizophrenia (CDSS)

    Time frame: Change from Depresión at 3-6-9 months (12 minutes)

    El cuestionario es un intrumento estructurado, adminisitrado por un clínico de forma heteroaplicada para población adulta, con un tiempo aproximado de administración de entre 10 y 30 minutos, y aborada el área terapéutica relativa a la sintomatología de los trastornos depresivos.

  4. Rosenberg Self-Esteem Scale

    Time frame: Change from self.-esteem at 3-6-9 months (12 minutes)

    The questionnaire consists of 10 statements of the feelings that the person has about himself. Five of the statements are addressed positively (items 1, 2, 4, 6 and 7) and 5 negatively (items 3, 5, 8, 9 and 10).

  5. Positive and negative symptom scale (PANSS)

    Time frame: Change from Positive and negative symptom at 3-6-9 months (12 minutes)

    It is a semi-structured and hetero-applied questionnaire for the adult population. The application time is between 30-60 minutes and evaluates the positive and negative symptoms of schizophrenia and other psychotic disorders.

Sponsors and collaborators

Lead sponsor

Miguel Monfort Montolio

Other

Registry information

Important dates

Study start
2015
Primary completion
2019
Study completion
2019
First posted
Nov 2, 2021
Registry last updated
Nov 2, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.